News

The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...
In mid-April 2025, social media users spread a rumor that U.S. President Donald Trump's administration would end animal ...
The FDA is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs.
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...
This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...
Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, ...
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...